An overview of recent metastatic HER2 breast cancer trials

Share :
Published: 27 Jan 2020
Views: 664
Prof Sandra Swain - Georgetown University Medical Centre, Washington, USA

Prof Sandra Swain spoke to ecancer at the BGICC 2020 conference in Cairo, Egypt about metastatic HER2 breast cancer.

After reminding us of the results of the CLEOPATRA trial, she also outlines the excellent results from SABCS concerning trastuzumab deruxtecan.

Following this, Prof Swain outlines the HER2CLIMB trial which looks at patients with brain metastases.